跳至主要内容
临床试验/NCT06744140
NCT06744140进行中(未招募)不适用

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Superior University1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
35
试验地点
1
主要终点
sensitivity & specificity

研究概览

简要总结

"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.

详细描述

Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts.

The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations).
  • Patients aged 30-65 years.
  • Patients willing to undergo breast MRI screening for DCIS detection.

排除标准

  • Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia).
  • Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.

结局指标

主要结局

sensitivity & specificity

时间窗: 12 Months

sensitivity \& specificity of MRI in detecting DCIS

BIRADS scores

时间窗: 12 Months

BIRADS scores will be used to evaluate the diagnostic accuracy of MRI in detecting DCIS

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Naveed Babur

Principal Investigator

Superior University

研究点 (1)

Loading locations...

相似试验